Clinical and Pathophysiological Considerations Related to the Impact of Bulevirtide, a New Entry Inhibitor, in HBV-HDV Infection

This review critically examines the inhibition of viral entry as an emerging disease-modifying strategy in chronic hepatitis B (HBV) and delta (HDV) virus infection, with particular emphasis on bulevirtide, the first-in-class of the sodium taurocholate cotransporting polypeptide entry inhibitor. Thi...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Raisa Eloise Barbu, Mariana Daniela Ignat, Roxana Elena Bogdan Goroftei, Alexia Anastasia Ștefania Baltă, Valerii Lutenco, Valentin Bulza, Valerian Ionuț Stoian, Simona Claudia Cambrea, Elena Dumea, Liliana Baroiu
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2026-04-01
Schriftenreihe:	Viruses
Schlagworte:	HBV/HDV coinfection bulevirtide viral entry inhibition
Online-Zugang:	https://www.mdpi.com/1999-4915/18/4/477
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!